Washington State University fired up the grill for “CRISPR sausages” made with pork from gene-edited pigs. WSU is the first university to make meat from gene-edited livestock available for human ...

Traditionally drugs and medicine have been created on a “one-size-fits-all” basis, and trials are used to establish which formulations are most beneficial to the widest segment of society. Today, ...

Phospholipases are a versatile group of enzymes that have gained prominence for their dual roles in biotechnology and industrial oil refining. In the context of oil degumming, these enzymes catalyse ...

PHILADELPHIA, Oct. 16, 2025/PRNewswire/ -- As infectious disease leaders gather in Atlanta for IDWeek 2025 (October 19–22), Philadelphia-based biotech, LIV Process is shining a light on one of ...

Had this article been published three to five years ago, the target audience would likely have been medical, bioprocess, or pharmaceutical biotechnologists focused on applying systems biology to areas ...

Palo Alto, Calif. -- March 9, 2004 – Exciting advances in biotechnology are driving the increasing acceptance of biotech products in several industries, especially pharmaceuticals, agriculture, and ...

As pharmaceutical manufacturing grows increasingly complex, Merck KGaA wants to ramp up its development capabilities for clinical trial compounds. The German life sciences company got one step closer ...

A consortium of companies in the European process industry including biotechnology, renewable resources, chemistry, process engineering, equipment and research organizations launched project PRODIAS ...

Noubar Afeyan, a cofounder of the coronavirus-vaccine maker Moderna, recently sat down with Insider. He shared the four steps used by his venture firm Flagship Pioneering to create companies. Flagship ...

'American Axle' could give rise to arguments that claims to processes of manufacturing chemical or biological compositions are not patent-eligible subject matter because they inherently require the ...

Given the complexity of alternative-protein manufacturing, many biotech companies are exploring how to reduce costs with AI technologies, process improvements and novel uses for waste streams from ...